Gastroenterology wRVU Compensation in 2026: Benchmarks, Endoscopy Volume, ASC Income, and What to Ask Before You Sign

Gastroenterology has among the highest per-wRVU rates of any specialty — $72 per wRVU at the MGMA 2025 median. The reason is the procedural mix: endoscopy, colonoscopy, ERCP, EUS, and other endoscopic procedures all carry high wRVU values. The income consequence is that GI compensation tracks almost entirely with procedural volume and the per-unit rate the contract pays. Both numbers can be quietly compressed in the contract structure, and the 2026 CMS efficiency adjustment hits gastroenterology harder than almost any other specialty.

If you are a gastroenterologist evaluating a contract — finishing fellowship, switching practices, or considering private group versus hospital employment — here is what the 2026 market actually looks like and where the financial issues hide.

What the 2026 gastroenterology benchmarks actually are

Based on MGMA 2025 data, the median gastroenterologist produces approximately 7,200 wRVUs annually at $72 per wRVU. Total compensation at the median runs $510,000-$560,000. Medscape 2026 ties GI with cardiology for total compensation at approximately $535,000 median.

The 75th percentile gastroenterologist produces around 9,000 wRVUs annually. The 90th percentile is 11,200 — typically reflecting a high-volume endoscopy practice with significant ASC ownership distributions on top of the wRVU compensation.

The per-wRVU rate of $72 is materially higher than most other specialties because endoscopic procedures carry higher RVU values per unit time. A diagnostic colonoscopy generates approximately 4 wRVUs in 30-45 minutes; a complex ERCP generates 8-12 wRVUs in 60-90 minutes. The hourly wRVU yield in the endoscopy suite is structurally higher than in clinic.

The 2026 CMS adjustment hits gastroenterology hard

CMS reduced wRVU values for procedural codes by 2.5% in January 2026. Gastroenterology is one of the specialties most affected. Diagnostic colonoscopy, screening colonoscopy with polypectomy, EGD, ERCP, and EUS all carry reduced wRVU values in 2026 versus 2025.

For a gastroenterologist producing 7,200 wRVUs annually under 2025 values, the same clinical work in 2026 produces approximately 7,020 wRVUs — a 2.5% reduction. At $72/wRVU, that is roughly $13,000 of lost annual income for the same clinical activity.

If your contract was drafted using 2025 MGMA data, your wRVU threshold is effectively 2.5% harder to hit in 2026. Ask explicitly: was the threshold in this contract benchmarked against 2025 or 2026 wRVU values? If it was set in 2025 and not adjusted, the practical effect is a structural pay cut that takes effect on the contract start date.

Fair contract language adjusts the threshold to reflect 2026 values, or includes a reconciliation clause that triggers when CMS changes wRVU values materially during the contract term.

The three gastroenterology contract traps

Endoscopy block time language that is not actually guaranteed. GI productivity depends on consistent endoscopy suite access. Most contracts include language like 'physician shall be allocated endoscopy block time consistent with the practice's procedural schedule.' That sentence sounds neutral but contains no actual commitment. In practice, endoscopy time is often allocated to senior partners first, with junior gastroenterologists taking whatever remains — often clinic-heavy schedules that produce lower wRVU yields per hour.

If your contract assumes 7,200 wRVUs of production but the endoscopy block time available to you supports only 5,500 wRVUs, your bonus compensation is structurally capped. Ask explicitly: how many endoscopy days per week am I guaranteed, and is that protected from being reassigned to senior partners?

ASC ownership terms with vesting periods longer than typical contract length. Many GI practices offer ambulatory surgery center ownership opportunities. These can be substantial — a meaningful stake in a high-volume GI ASC can generate $200,000-$600,000 annually in distributions. But vesting terms often extend 5-7 years, and many contracts include language allowing the ASC to repurchase your stake at book value if you leave before vesting completes.

Book value of an ASC stake is typically a small fraction of fair market value. If you sign a 3-year contract with a 5-year ASC vesting schedule, you have created an automatic financial penalty for changing jobs that may not be obvious at the time of signing.

Procedure mix language that affects bonus calculation. Some GI contracts include incentive language tied to specific procedure volumes — 'physician shall earn $X bonus per quarter for performing more than Y screening colonoscopies' or similar. This sounds like upside but creates a financial incentive that can conflict with appropriate clinical decision-making and is often structured such that the volume thresholds require significantly altering practice patterns.

Read these provisions carefully. Volume-based incentives are not inherently wrong, but they should be transparent, achievable based on existing practice patterns, and not create pressure to perform procedures of questionable indication.

What fair gastroenterology contract language looks like

On the wRVU structure: a threshold at or below the 50th percentile (around 7,200 wRVUs) with a rate at or above $72/wRVU, explicitly benchmarked against 2026 (not 2025) MGMA data with a reconciliation clause for further CMS changes.

On endoscopy block time: a guaranteed minimum number of endoscopy days per week, protection from being reassigned to senior partners, and a clear make-up policy for facility-cancelled days.

On ASC ownership: explicit vesting schedule, buyout methodology that reflects fair market value (not book value), and disclosed historical distributions over the past 3-5 years.

What to ask before you sign

Four specific questions worth getting answered in writing before you commit to a gastroenterology contract:

1. Was the wRVU threshold in this contract benchmarked against 2025 or 2026 MGMA values, given the 2.5% CMS efficiency adjustment to procedural codes?
2. How many endoscopy days per week am I guaranteed, is that protected from reassignment to senior partners, and what is the make-up policy for facility-cancelled days?
3. If this contract includes ASC ownership opportunity, what is the vesting schedule, the buyout methodology if I leave before vesting, and the historical annual distribution amount?
4. What was the average total compensation paid to gastroenterologists at the practice over the past 3 years, and how does that compare to the implied compensation in this offer?

These are the questions that separate a $510,000 contract from a $750,000 contract over a 5-year term once ASC distributions are factored in. Vague answers on endoscopy time, ASC vesting, or 2026 CMS adjustments tell you exactly how the math will work in practice.

Want to know how your specific gastroenterology contract compares to these benchmarks? FairRVU runs the full analysis in 60 seconds — wRVU threshold percentile, endoscopy block time analysis, ASC vesting evaluation, and 2026 CMS adjustment impact. Your contract is permanently deleted after processing.